-
May 23, 2024, 05:00 AM
by
User Not Found
Bio-IT World | John Damask is a cloud proponent; he makes no apologies for that. And his experience has mostly been with Amazon Web Services; he is clear on that too. With those disclosures out of the way, Damask offered a “Choose Your Own Adventure”-style tour of cloud best practices and the most common startup cloud mistakes at last month’s Bio-IT World Conference & Expo, letting the audience choose the topics he dug into during the talk.
Full story
-
May 22, 2024, 07:33 AM
by
Full story
-
May 22, 2024, 05:00 AM
by
User Not Found
Bio-IT World | At the 2024 Bio-IT World Conference & Expo, artificial intelligence (AI) was the main topic stirring up discussions and debates, especially generative AI and its data platforms. Data platforms are crucial tools for AI models, yet there are several barriers that hinder their utilization, efficiency, and accessibility —and none of them are technical or data-related.
Full story
-
May 21, 2024, 09:10 AM
by
DrFirst Announces 2024 Healthiverse Heroes Award Winners
https://www.prnewswire.com/news-releases/drfirst-announces-2024-healthiverse-heroes-award-winners-302150945.html?tc=eml_cleartime
Full story
-
May 21, 2024, 09:10 AM
by
Full story
-
May 21, 2024, 09:10 AM
by
CG Life, a science-first, tech-enabled agency, acquires Berry & Company Public Relations. The acquisition significantly expands the range of CG Life communications expertise and services to support clients in the biopharma and medical sectors.
Full story
-
May 21, 2024, 05:28 AM
by
User Not Found
Bio-IT World | In the not-too-distant future, disorders of the brain could be treated with the same precision as heart disease and cancer. The means will be a therapeutic brain-computer interface (BCI) the size of a small blueberry for people suffering from treatment-resistant depression that uses a similar type of implant technology as Elon Musk’s Neuralink for helping paralyzed people speak.
Full story
-
May 20, 2024, 08:13 AM
by
Huateng Pharma, a leader in innovative pharmaceutical solutions, is excited to announce the launch of its latest product, Piroctone Olamine (CAS No. 68890-66-4).
Full story
-
May 20, 2024, 08:13 AM
by
Biopharma PEG, a renowned leader in the development and supply of high-quality polyethylene glycol (PEG) derivatives, is pleased to announce its participation in the BIO International Convention 2024. The event will take place from June 3-6, 2024, at the San Diego Convention Center, and attendees can visit Biopharma PEG at Booth 5102.
Full story
-
May 17, 2024, 07:46 AM
by
Rob Sobie to support IntelliGuard’s ongoing innovation to track, trace, and improve safety in medication inventory
Full story
-
May 17, 2024, 07:46 AM
by
Precision medicine biotechnology company for obesity secures additional institutional capital from prominent industry leaders to expand the use of its novel phenotyping test and advance clinical research in weight loss treatment.
Full story
-
May 17, 2024, 07:46 AM
by
https://www.prnewswire.com/news-releases/lindus-health-announces-cosmetics-clinical-trial-with-acinonyx-bio-to-evaluate-an-alternative-to-benzoyl-peroxide-for-inflammatory-acne-302146936.html?tc=eml_cleartime
Full story
-
May 17, 2024, 07:46 AM
by
https://www.prnewswire.com/news-releases/mdclone-earns-fourth-consecutive-best-healthcare-big-data-platform-award-from-medtech-breakthrough-302147956.html?tc=eml_cleartime
Full story
-
May 17, 2024, 07:46 AM
by
Today, The British Journal of Nutrition published a study that found the consumption of a daily prebiotic fibre supplement helped to improve insulin sensitivity and other important health markers in patients with pre-diabetes
Full story
-
May 17, 2024, 07:46 AM
by
Full story
-
May 16, 2024, 08:08 AM
by
Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards
Full story
-
May 16, 2024, 08:08 AM
by
Icosagen announces a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC) to discover novel monoclonal antibodies.
Full story
-
May 16, 2024, 08:08 AM
by
IDT and Molecular Health have entered into a global multi-year agreement, starting in the U.S., to integrate their NGS capabilities.
Full story
-
May 16, 2024, 08:08 AM
by
Inceptua Group announces an expansion of an Early Access Program for cefiderocol for eligible patients in Argentina, Chile, Colombia, Guatemala, Mexico, and Panama.
Full story
-
May 16, 2024, 08:08 AM
by
Vector Laboratories joins forces with Absolute Biotech, bolstering its role as a key manufacturer for life science customers, enriching its antibody reagents portfolio, and expanding its commercial presence into the UK and EU.
Full story